Before joining CIC Ian was a Director at Unilever Ventures in London, where he led all B2B/Technology investments.
Over 11 years he was responsible for numerous transactions across Europe and North America, including investments into Olapic (acquired by Monotype Inc), Mirakl, Aera Technology, Skupos, WeGift, Celtra (acquired by STG), CreatorIQ, Mirriad (Listed on AIM) and Blis Global (acquired by LDC).
Prior to Unilever Ventures, Ian worked at L.E.K. Consulting in London and Australia, working on strategy consulting and private equity due-diligence projects.
Ian has a PhD in Physical Chemistry from the University of Cambridge and MSci in Chemistry from Bristol University.
Ian manages CIC's investment in Seldon, Cambridge GaN Devices, Salience Labs, Unlikely AI, AudioTelligence and Secondmind.